Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 19 - Sep 24
Prevnar family (pneumococcal 13-valent conjugate vaccine) Disease area(s): Vaccines/infectious diseases Manufacturer(s): Pfizer 2024 Sales (USD): $6.41 billion Why it sold so well: In 2024, Pfizers Prevnar family of pneumococcal vaccines generated $6.4 billion in global revenue, accounting for 10% of the companys total revenue and ranking as its second-highest-selling product after Eliquis
The supplement is made in Germany by veterinarians and pet experts
DK: Writing review & editing
Many reports showed that GLP-1 effects involve neural modulation and peripheral effects, which increase satiety, resting energy expenditure and lower plasma concentrations of free fatty acids [20]-[22]
US$ 25.73
US$ 23.38
US$ 22.48
US$ 29.74
US$ 25.49
US$ 25.04
US$ 29.86
US$ 28.15
